H. CRAIG DEES, PH.D. - Corporate Board Profile

PROVECTUS BIOPHARMACEUTICALS, INC.

Filing Date	Source Excerpt
2003-04-30	H. Craig Dees, Ph.D., 51, Director. Dr. Dees has served as our Chief Executive Officer and as a member of our Board of Directors since we acquired PPI on April 23, 2002. ... They are compensated for their service in those roles. They are not separately compensated for their service as directors. ... The table below shows the annual, long-term and other compensation for services in all capacities to the Company and its subsidiaries paid during the year ended December 31, 2002 to our Chief Executive Officer and the other four most highly compensated executive officers of the Company during the year ended December 31, 2002 ... H. Craig Dees, Chief Executive Officer (2) 2002 $ 18,750 $ 0 $ 0 $ 0 $ 18,750
2005-04-21	H. Craig Dees, Ph.D., 53, has served as our Chief Executive Officer and as a member of our Board of Directors since we acquired PPI on April 23, 2002. ... The Board of Directors acting as the Audit Committee: H. Craig Dees ... As discussed below under the heading EXECUTIVE OFFICER COMPENSATION, they are compensated for their service in those roles. They are not separately compensated for their service as directors. ... Summary Compensation Table ... H. Craig Dees 2004 Salary $175,000 + All Other Compensation $91,666 = $266,666 (rounded to 266,499)
2006-04-28	H. Craig Dees, Ph.D., 54, has served as our Chief Executive Officer and as a member of our Board of Directors since we acquired Provectus Pharmaceuticals, Inc., a privately held Tennessee Corporation, on April 23, 2002. ... The entire Board of Directors acts as our audit committee as permitted under Section 3(a)(58)(B) of the Securities Exchange Act of 1934 and as our nominating committee. ... The table below shows the compensation for services in all capacities we paid during the year ended December 31, 2005 to our Chief Executive Officer and the other executive officers during the year ended December 31, 2005 who received more than $100,000: ... H. Craig Dees. Chief Executive Officer 2005 Salary ($) 229,166
2007-04-27	H. Craig Dees, Ph.D., 55, has served as our Chief Executive Officer and as a member of our Board of Directors since we acquired Provectus Pharmaceuticals, Inc., a privately held Tennessee Corporation, on April 23, 2002. ... Three of our four directors, Drs. Dees, Scott and Wachter, are also full-time employees. As discussed below under the heading “EXECUTIVE OFFICER COMPENSATION,” they are compensated for their service in those roles. Other than the options described below, they are not separately compensated for their service as directors. ... Summary Compensation Table ... H. Craig Dees, CEO ... Total ($) 950,137 ... The entire Board of Directors acts as our audit committee as permitted under Section 3(a)(58)(B) of the Securities Exchange Act of 1934 and as our nominating committee.
2012-04-30	H. Craig Dees, Ph.D., 60, has served as our Chief Executive Officer and as a member of our Board of Directors since we acquired Provectus Pharmaceuticals, Inc., a privately held Tennessee Corporation, on April 23, 2002. Dr. Dees is our Chief Executive Officer and serves as chairman of our Board of Directors. Our entire Board of Directors acts as our audit committee, nominating committee, and compensation committee. The table below shows the compensation for services in all capacities we paid during the years ended December 31, 2011, 2010 and 2009 to our Chief Executive Officer... The table below shows the compensation for services in all capacities we paid during the years ended December 31, 2011, 2010 and 2009 to our Chief Executive Officer, Chief Financial Officer (2011 only) and our two other executive officers (whom we refer to as named executive officers): H. Craig Dees CEO 2011 Salary $500,000 Option Awards $1,600,000 All Other Compensation $57,692 Total $2,978,714
2013-04-30	H. Craig Dees, Ph.D., 61, has served as our Chief Executive Officer and as a member of our board of directors since we acquired Provectus Pharmaceuticals, Inc., a privately held Tennessee corporation ("PPI"), on April 23, 2002. ... Dr. Dees is has extensive experience researching, developing, and testing potential pharmaceutical products, including our products. He holds a Ph.D. in Molecular Virology, which we believe provides us with specialized knowledge in that field. ... Two of our five directors, Drs. Dees and Scott, are also full-time employees. As discussed above under the heading "COMPENSATION DISCUSSION AND ANALYSIS," they are compensated for their service in those roles. Other than the options received for service as directors, as described below, they are not separately compensated for their service as directors. ... The table below shows the compensation for services in all capacities we paid during the years ended December 31, 2012, 2011 and 2010 to our Chief Executive Officer, Chief Financial Officer (2012 and 2011 only) and our two other executive officers (whom we refer to as named executive officers): ... H. Craig Dees CEO 2012 $ 500,000 600,000 36,163 90,692 1,226,855
2014-04-30	H. Craig Dees, Ph.D., 62, has served as our Chief Executive Officer and as a member of our board of directors since we acquired Provectus Pharmaceuticals, Inc., a privately held Tennessee corporation ("PPI"), on April 23, 2002. ... Dr. Dees is our Chief Executive Officer and serves as chairman of our Board of Directors. ... Other than the options received for service as directors, as described below, they are not separately compensated for their service as directors. ... The table below shows the compensation for services in all capacities we paid during the years ended December 31, 2013, 2012 and 2011 to our Chief Executive Officer, Chief Financial Officer and our two other executive officers (whom we refer to collectively as our "named executive officers"): ... H. Craig Dees CEO 2013 $500,000 salary, no bonus, $28,462 option awards, $114,192 all other compensation, total $642,654.
2015-04-30	H. Craig Dees, Ph.D., 63, has served as our Chief Executive Officer and as a member of our board of directors since we acquired Provectus Pharmaceuticals, Inc., a privately held Tennessee corporation ("PPI"), on April 23, 2002. ... Dr. Dees is our Chief Executive Officer and serves as chairman of our Board of Directors. ... The table below shows the compensation for services in all capacities we paid during the years ended December 31, 2014, 2013 and 2012 to our Chief Executive Officer, Chief Financial Officer and our two other executive officers (whom we refer to collectively as our "named executive officers"): ... H. Craig Dees CEO 2014 $ 500,000 salary, $0 bonus, $0 option awards, $0 all other compensation, $137,692 total other compensation, $637,692 total compensation.
2016-11-02	Dr. Dees resigned as Chief Executive Officer and Chairman of the Board of Directors effective February 27, 2016.